The results revealed that, although the 10058-F4 treatment did not impact tumor growth, it markedly abolished the phenotype of enhanced tumor necrosis and hypoxia in RBPj knockout mice (Figure 4A-B, S4G). The gene discussed is RBPJ; the disease is neoplasm.